Clinical Trials Logo

Ocular Motility Disorders clinical trials

View clinical trials related to Ocular Motility Disorders.

Filter by:

NCT ID: NCT03248336 Recruiting - Clinical trials for Convergence Insufficiency

Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children

Start date: September 2, 2018
Phase: N/A
Study type: Interventional

This study is designed to evaluate changes in objective measures of disparity vergence after office-based vergence/accommodative therapy (OBVAT) for convergence insufficiency (CI) in children 12-17 years old.

NCT ID: NCT03123822 Terminated - Concussion, Mild Clinical Trials

Spectacles Lens in Concussed Kids

SLICK
Start date: October 31, 2017
Phase: N/A
Study type: Interventional

We will be looking at 3 treatment arms in the form of different type of glasses to see if one is superior to helping kids have sustained a concussion and are symptomatic.

NCT ID: NCT03059420 Recruiting - Facial Palsy Clinical Trials

Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies

Start date: February 1, 2004
Phase:
Study type: Observational

The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.

NCT ID: NCT02981875 Completed - Clinical trials for Ocular Motility Disorders

Oculomotor Training Improves Reading Eye Movement

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Children with reading eye movement problems were recruited for this study. The treatment group was provided with oculomotor training for 8 weeks, the control group was given placebo exercises.

NCT ID: NCT02607384 Completed - Refractive Error Clinical Trials

The Baltimore Reading and Eye Disease Study

BREDS
Start date: November 2014
Phase: N/A
Study type: Interventional

The Baltimore Reading and Eye Disease Study (BREDS) is a two year study to determine the prevalence of vision problems in an early school age population with reading difficulty. Comprehensive vision and reading tests will be administered to 400 students at participating schools in the Baltimore City Public School system. A secondary goal is to examine the impact of vision treatment on reading performance. Children with refractive error or convergence insufficiency will be provided treatment free of charge. The investigators will evaluate the impact that the treatment has on vision function and reading performance.

NCT ID: NCT02510040 Completed - Clinical trials for Convergence Insufficiency

A Prospective Observational Study of Adult Strabismus

SAS1
Start date: August 17, 2015
Phase:
Study type: Observational

The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.

NCT ID: NCT02391961 Completed - Multiple Sclerosis Clinical Trials

Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis

Start date: April 1, 2015
Phase: Phase 2
Study type: Interventional

Primary fatigue represents a major cause of disability in patients with multiple sclerosis (MS), being reported in about 90% of cases. Fatigue interferes with everyday functioning but, unfortunately, little is known about its mechanisms. The investigators propose a characteristic eye movement abnormality (internuclear ophthalmoparesis, INO), commonly encountered in MS, as a simple model for primary motor fatigue. The investigators described worsening of ocular performance in MS patients with INO following visual tasks (ocular motor fatigue), which is likely due to decreased neural conduction along brain pathways injured by MS. This mechanism could represent a major component of MS-related primary motor fatigue. Relevant to Veterans' care, INO is a significant cause of visual disability, especially when complicated by ocular fatigue, and limits daily activities such as reading and driving. The investigators propose a medical treatment to improve ocular performance/fatigue in INO, which can reduce visual disability and improve quality of life in Veterans with MS.

NCT ID: NCT02251002 Completed - Clinical trials for TBI (Traumatic Brain Injury)

Frontoparietal Priority Maps as Biomarkers for MTBI

Start date: July 2015
Phase:
Study type: Observational

The purpose of this study is to determine whether there is a quantitative relationship between brain processes seen by a MRI and visual deficits caused by mild to moderate traumatic brain injuries (mTBI).

NCT ID: NCT02207517 Active, not recruiting - Clinical trials for Convergence Insufficiency

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

CITT-ART
Start date: May 2014
Phase: Phase 3
Study type: Interventional

CITT-ART is a multicenter study (8 locations around the United States) of 324 children ages 9 to <14 years with symptomatic convergence insufficiency (CI). The purpose of this study is to see if office-based therapy for convergence insufficiency (CI) improves reading ability and attention. CI is an eye-teaming problem where the eyes would like to drift outward when reading or doing close work. When eyes drift out, double vision can happen. To prevent double vision one must use extra effort to keep the eyes from going out. This extra effort can cause symptoms that can interfere with reading and working comfortably at near. These symptoms often include eyestrain, blurred vision, headaches, double vision, and loss of place when reading or performing tasks at near. In a prior study we found that therapy improves these symptoms. In this study we are looking at whether the therapy improves reading and attention

NCT ID: NCT01868269 Active, not recruiting - Neuroblastoma Clinical Trials

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Start date: April 18, 2013
Phase: Phase 3
Study type: Interventional

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (European Paediatric Neurology Society), the GPOH (Gesellschaft für Pädiatrische Hematologic und Oncologie) and the SIOPEN (SIOP (International Society Oncology Pediatric) Europe Neuroblastoma). This protocol will investigate an escalating treatment schedule starting with a corticosteroid standard treatment with dexamethasone pulses (first step), which is followed, if response has been inadequate after 3 months of treatment, by the addition of CP (second step) and, if still no sufficient improvement, by the replacement of CP by Rituximab (third step). Treatment intensification is decided on the basis of standardized scoring of OMS/DES severity.